A healthier you, made simple and affordable.
A healthier you, made simple and affordable.
A healthier you, made simple and affordable.
Our Mochi doctors prescribe the most effective and appropriate medication for our patients. We provide all options from GLP-1's to generic medication. Read over what medications we prescribe below!
Our Mochi doctors prescribe the most effective and appropriate medication for our patients. We provide all options from GLP-1's to generic medication. Read over what medications we prescribe below!
Our Mochi doctors prescribe the most effective and appropriate medication for our patients. We provide all options from GLP-1's to generic medication. Read over what medications we prescribe below!
Medications
Injectables
Oral
Compounded Medication
A Mochi provider may prescribe a compounded medication if they determine that such medication is an appropriate part of your course of treatment. Find out if you’re eligible below.
How it works
Compounded medications are custom-prepared to meet an individual patient's specific needs. For example, they may include a specific dosage strength not available commercially or additional active ingredients clinically indicated for the patient. These medications are created by licensed pharmacies, based on a valid prescription from a licensed provider. While they are not FDA-approved (meaning they haven’t gone through the FDA drug approval process), they are still regulated at the state and/or federal level, and must meet important safety and quality standards.
Expected results
Results may vary depending on individual goals and health status. Talk with your Mochi provider to understand what to expect when taking compounded medication. They'll work with you to determine the most effective treatment plan for your needs.
Side effects
Side effects depend on the medication prescribed and individual tolerance. Common side effects of compounded GLP-1 medication include nausea, vomiting, and diarrhea, and they typically subside within a few weeks of initiation or dose increase. Your provider will help you monitor and manage side effects.
Avoid when
History of thyroid C-cell tumors; pregnant; breastfeeding; trying to conceive; history of anorexia/bulimia. Other contraindications may be present – providers will review health history to determine whether a prescription is appropriate.
Wegovy® / Ozempic®
Active ingredient: Semaglutide
Semaglutide is a GLP-1 agonist created for Type 2 Diabetes and FDA-approved in 2019. It was approved for the indication of weight loss as Wegovy® in June 2021.
How it works
GLP-1 works to increase insulin levels by activating cells in the pancreas. It also triggers hormone release to delay the emptying of the stomach, sometimes causing nausea.
Expected results
When used alongside robust lifestyle management (200 min exercise/week, nutri-system diet, bimonthly nutritionist visits) patients observed 10-14% weight loss, maintained over 2 years (STEP3 Trial, Novo Nordisk). (Wilding et al., 2021)
Side effects
Nausea (44%); vomiting (25%); diarrhea/GI distress (30%)
Avoid when
History of thyroid C-cell tumors; pregnant; breastfeeding; trying to conceive; history of anorexia/bulimia
Mounjaro® / Zepbound®
Active ingredient: Tirzepatide
Tirzepatide is the newest form of weight loss medication. It was recently approved for Type 2 diabetes, and works through both the GLP-1 receptor and GIP receptors.
How it works
Both GLP-1 and GIP receptors work to decrease the rate your stomach empties-keeping you full for longer! They also work to decrease your appetite and cravings.
Expected results
The SURMOUNT-1 trial showed expected weight loss of 22.5%. Additional trials have shown this medication is twice as effective as Semaglutide 1.0mg. (Aronne et al., 2024)
Side effects
Nausea (44%); vomiting (25%); diarrhea/GI distress (30%)
Avoid when
Chronic malabsorption; pregnancy; cholestasis/history of gallbladder disease; pancreatitis; family history of thyroid cancer; thyroid disorders
Saxenda® / Victoza®
Active ingredient: Liraglutide
Liraglutide is a GLP-1 agonist medication, very similar to Semaglutide. It was initially developed as a medication for Type 2 Diabetes, but found to also help patients with weight loss.
How it works
By activating GLP-1 receptors, this medication works to slow the rate at which your stomach empties, and to send signals to your brain to decrease appetite.
Expected results
The SCALE Trial showed patients can lose 6.2% over 52 weeks (CI 7.5 to 4.6%). (Rubino et al., 2022)
Side effects
Nausea (44%); vomiting (25%); diarrhea/GI distress (30%)
Avoid when
Pancreatitis gallstones; family history of thyroid cancer; thyroid disorders
Medications
Injectables
Oral
Compounded Medication
A Mochi provider may prescribe a compounded medication if they determine that such medication is an appropriate part of your course of treatment. Find out if you’re eligible below.
How it works
Compounded medications are custom-prepared to meet an individual patient's specific needs. For example, they may include a specific dosage strength not available commercially or additional active ingredients clinically indicated for the patient. These medications are created by licensed pharmacies, based on a valid prescription from a licensed provider. While they are not FDA-approved (meaning they haven’t gone through the FDA drug approval process), they are still regulated at the state and/or federal level, and must meet important safety and quality standards.
Expected results
Results may vary depending on individual goals and health status. Talk with your Mochi provider to understand what to expect when taking compounded medication. They'll work with you to determine the most effective treatment plan for your needs.
Side effects
Side effects depend on the medication prescribed and individual tolerance. Common side effects of compounded GLP-1 medication include nausea, vomiting, and diarrhea, and they typically subside within a few weeks of initiation or dose increase. Your provider will help you monitor and manage side effects.
Avoid when
History of thyroid C-cell tumors; pregnant; breastfeeding; trying to conceive; history of anorexia/bulimia. Other contraindications may be present – providers will review health history to determine whether a prescription is appropriate.
Wegovy® / Ozempic®
Active ingredient: Semaglutide
Semaglutide is a GLP-1 agonist created for Type 2 Diabetes and FDA-approved in 2019. It was approved for the indication of weight loss as Wegovy® in June 2021.
How it works
GLP-1 works to increase insulin levels by activating cells in the pancreas. It also triggers hormone release to delay the emptying of the stomach, sometimes causing nausea.
Expected results
When used alongside robust lifestyle management (200 min exercise/week, nutri-system diet, bimonthly nutritionist visits) patients observed 10-14% weight loss, maintained over 2 years (STEP3 Trial, Novo Nordisk). (Wilding et al., 2021)
Side effects
Nausea (44%); vomiting (25%); diarrhea/GI distress (30%)
Avoid when
History of thyroid C-cell tumors; pregnant; breastfeeding; trying to conceive; history of anorexia/bulimia
Mounjaro® / Zepbound®
Active ingredient: Tirzepatide
Tirzepatide is the newest form of weight loss medication. It was recently approved for Type 2 diabetes, and works through both the GLP-1 receptor and GIP receptors.
How it works
Both GLP-1 and GIP receptors work to decrease the rate your stomach empties-keeping you full for longer! They also work to decrease your appetite and cravings.
Expected results
The SURMOUNT-1 trial showed expected weight loss of 22.5%. Additional trials have shown this medication is twice as effective as Semaglutide 1.0mg. (Aronne et al., 2024)
Side effects
Nausea (44%); vomiting (25%); diarrhea/GI distress (30%)
Avoid when
Chronic malabsorption; pregnancy; cholestasis/history of gallbladder disease; pancreatitis; family history of thyroid cancer; thyroid disorders
Saxenda® / Victoza®
Active ingredient: Liraglutide
Liraglutide is a GLP-1 agonist medication, very similar to Semaglutide. It was initially developed as a medication for Type 2 Diabetes, but found to also help patients with weight loss.
How it works
By activating GLP-1 receptors, this medication works to slow the rate at which your stomach empties, and to send signals to your brain to decrease appetite.
Expected results
The SCALE Trial showed patients can lose 6.2% over 52 weeks (CI 7.5 to 4.6%). (Rubino et al., 2022)
Side effects
Nausea (44%); vomiting (25%); diarrhea/GI distress (30%)
Avoid when
Pancreatitis gallstones; family history of thyroid cancer; thyroid disorders
Medications
Injectables
Oral
Compounded Medication
A Mochi provider may prescribe a compounded medication if they determine that such medication is an appropriate part of your course of treatment. Find out if you’re eligible below.
How it works
Compounded medications are custom-prepared to meet an individual patient's specific needs. For example, they may include a specific dosage strength not available commercially or additional active ingredients clinically indicated for the patient. These medications are created by licensed pharmacies, based on a valid prescription from a licensed provider. While they are not FDA-approved (meaning they haven’t gone through the FDA drug approval process), they are still regulated at the state and/or federal level, and must meet important safety and quality standards.
Expected results
Results may vary depending on individual goals and health status. Talk with your Mochi provider to understand what to expect when taking compounded medication. They'll work with you to determine the most effective treatment plan for your needs.
Side effects
Side effects depend on the medication prescribed and individual tolerance. Common side effects of compounded GLP-1 medication include nausea, vomiting, and diarrhea, and they typically subside within a few weeks of initiation or dose increase. Your provider will help you monitor and manage side effects.
Avoid when
History of thyroid C-cell tumors; pregnant; breastfeeding; trying to conceive; history of anorexia/bulimia. Other contraindications may be present – providers will review health history to determine whether a prescription is appropriate.
Wegovy® / Ozempic®
Active ingredient: Semaglutide
Semaglutide is a GLP-1 agonist created for Type 2 Diabetes and FDA-approved in 2019. It was approved for the indication of weight loss as Wegovy® in June 2021.
How it works
GLP-1 works to increase insulin levels by activating cells in the pancreas. It also triggers hormone release to delay the emptying of the stomach, sometimes causing nausea.
Expected results
When used alongside robust lifestyle management (200 min exercise/week, nutri-system diet, bimonthly nutritionist visits) patients observed 10-14% weight loss, maintained over 2 years (STEP3 Trial, Novo Nordisk). (Wilding et al., 2021)
Side effects
Nausea (44%); vomiting (25%); diarrhea/GI distress (30%)
Avoid when
History of thyroid C-cell tumors; pregnant; breastfeeding; trying to conceive; history of anorexia/bulimia
Mounjaro® / Zepbound®
Active ingredient: Tirzepatide
Tirzepatide is the newest form of weight loss medication. It was recently approved for Type 2 diabetes, and works through both the GLP-1 receptor and GIP receptors.
How it works
Both GLP-1 and GIP receptors work to decrease the rate your stomach empties-keeping you full for longer! They also work to decrease your appetite and cravings.
Expected results
The SURMOUNT-1 trial showed expected weight loss of 22.5%. Additional trials have shown this medication is twice as effective as Semaglutide 1.0mg. (Aronne et al., 2024)
Side effects
Nausea (44%); vomiting (25%); diarrhea/GI distress (30%)
Avoid when
Chronic malabsorption; pregnancy; cholestasis/history of gallbladder disease; pancreatitis; family history of thyroid cancer; thyroid disorders
Saxenda® / Victoza®
Active ingredient: Liraglutide
Liraglutide is a GLP-1 agonist medication, very similar to Semaglutide. It was initially developed as a medication for Type 2 Diabetes, but found to also help patients with weight loss.
How it works
By activating GLP-1 receptors, this medication works to slow the rate at which your stomach empties, and to send signals to your brain to decrease appetite.
Expected results
The SCALE Trial showed patients can lose 6.2% over 52 weeks (CI 7.5 to 4.6%). (Rubino et al., 2022)
Side effects
Nausea (44%); vomiting (25%); diarrhea/GI distress (30%)
Avoid when
Pancreatitis gallstones; family history of thyroid cancer; thyroid disorders
